Idaho Gov. Brad Little – Photo: Phil White / Office of the Governor of Idaho
Idaho Republican Gov. Brad Little signed a bill into law prohibiting Medicaid and state employee health plans from covering the cost of gender-affirming medications and procedures for low-income transgender adults and minors.
House Bill 668 declares that public funds “shall not reimburse or provide coverage for any surgical operation or medical intervention…for purposes of altering the appearance of an individual in order to affirm the individual’s perception of the individual’s sex in a way that is inconsistent with the individual’s biological sex.”
The bill contains exemptions for certain types of surgical operations or medical interventions, such as those deemed medically necessary; those meant to force intersex people or those with “a medically verifiable genetic disorder of sex development” to conform to binary bodily stereotypes; and those used to help a person “de-transition” or to treat an “infection, injury, disease or disorder that has been caused or exacerbated by” gender-affirming surgery.
It also declares that any transition-related procedures performed to alter a person’s appearance to align with their gender identity, rather than their assigned sex at birth, does not qualify as “medically necessary.”
Because the bill prohibits “public funds,” state employees, like teachers or government workers, are barred from using their employer-sponsored health plan to cover the cost of gender-affirming treatments for themselves or their dependents, reports the Idaho Capital Sun.
The measure’s backers argue that it is necessary to prevent taxpayer dollars from being wasted on efforts to affirm a person’s gender identity.
A sponsor of a nearly identical measure argued that the bill does not completely ban transgender people from obtaining coverage for medical procedures or medications — just as long as those aren’t related to their transition.
“While I have great compassion for those who struggle with these issues [of gender dysphoria], I also understand that the idea of actually creating the function of the opposite sex is a scientific impossibility,” State Rep. Julianne Young (R-Blackfoot), the sponsor of the similar-in-scope House Bill 520 said during debate.
House Bill 668 ultimately passed the Idaho House of Representatives by a 58-11 vote, and the Idaho Senate by a 26-8 vote. If no legal challenge is mounted against the law, it will take effect on July 1.
A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir -- marketed as Yeztugo by Gilead Sciences -- do not have clinically significant interactions with gender-affirming hormone therapy.
"In the most gender-diverse Phase III PrEP trial conducted to date, lenacapavir had no clinically significant impact on feminizing or masculinizing gender-affirming therapy concentrations," the study’s researchers concluded, as reported by POZ.
The study, led by Dr. Jill Blumenthal of the University of California San Diego, examined whether lenacapavir interacts with gender-affirming hormone therapy, including estradiol (a form of estrogen) and testosterone. Because those hormones are metabolized by enzymes such as CYP3A4 -- which lenacapavir can inhibit -- the researchers analyzed whether the drug altered hormone levels.
The U.S. House of Representatives voted largely along party lines to advance a bill that would imprison doctors for providing gender-affirming care to transgender minors and punish parents who consent to their child’s treatment.
The bill, introduced by U.S. Rep. Marjorie Taylor Greene (R-Ga.), would impose prison sentences of up to 10 years on medical providers who recommend or prescribe puberty blockers, hormone therapy, or surgery to transgender patients under 18. It would also criminalize parents who consent to their child’s treatment or transport them across state lines to obtain such care.
The U.S. Department of Health and Human Services has launched an investigation into Seattle Children's Hospital over its alleged provision of gender-affirming care to transgender minors, a practice the Trump administration has aggressively sought to end.
In a post on X, the HHS official account said the hospital had been referred to the Office of the Inspector General for "failure to meet professional recognized standards of health care" under a declaration issued on December 18 by HHS Secretary Robert F. Kennedy, Jr., according to The Hill.
These are challenging times for news organizations. And yet it’s crucial we stay active and provide vital resources and information to both our local readers and the world. So won’t you please take a moment and consider supporting Metro Weekly with a membership? For as little as $5 a month, you can help ensure Metro Weekly magazine and MetroWeekly.com remain free, viable resources as we provide the best, most diverse, culturally-resonant LGBTQ coverage in both the D.C. region and around the world. Memberships come with exclusive perks and discounts, your own personal digital delivery of each week’s magazine (and an archive), access to our Member's Lounge when it launches this fall, and exclusive members-only items like Metro Weekly Membership Mugs and Tote Bags! Check out all our membership levels here and please join us today!
You must be logged in to post a comment.